Bronchial Blockers vs Double-Lumen Tubes in Obese Patients
One-lung Ventilation With Double-Lumen Tubes and Bronchial Blockers in Obese Patients Undergoing Lung Resection
1 other identifier
interventional
46
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2024
CompletedFirst Submitted
Initial submission to the registry
June 11, 2025
CompletedFirst Posted
Study publicly available on registry
June 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedJune 22, 2025
June 1, 2025
1.6 years
June 11, 2025
June 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypoxia
While its definition is somewhat arbitrary, the investigators consider hypoxia as SpO₂ \< 90%, while maintaining FiO₂ = 1.0, in accordance to our hospital guidelines.
Intraoperative (both from anesthetic induction to one-lung ventilation, and during one-lung ventilation)
Secondary Outcomes (21)
Lung collapse
Intraoperative
Surgical visualization
Intraoperative
Insertion time of the ventilation device
Intraoperative
Repositioning of the ventilation device
Intraoperative
Ventilation device change
Intraoperative
- +16 more secondary outcomes
Other Outcomes (22)
Sex
Preoperative
Age
Preoperative
Obesity
Preoperative
- +19 more other outcomes
Study Arms (2)
Bronchial Blocker
EXPERIMENTALPatients undergoing lung resection who receive one-lung ventilation using a bronchial blocker.
Double-Lumen Tube
EXPERIMENTALPatients undergoing lung resection who receive one-lung ventilation using a double-lumen tube.
Interventions
To achieve the required one-lung ventilation during lung resection, patients will be managed with a double-lumen tube.
To achieve the required one-lung ventilation during lung resection, patients will be managed with a bronchial blocker.
Eligibility Criteria
You may qualify if:
- BMI ≥ 30 kg/m2
- Diagnostic or clinical suspicion of lung cancer
- Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation.
- Use of bronchial blocker or double-lumen tube for one-lung ventilation.
You may not qualify if:
- Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated.
- Emergency surgeries.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Son Espases
Palma de Mallorca, Balearic Islands, 07120, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paulo Andrés Cano, MD
Hospital Son Espases
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients do not know which device will be used during their surgery, as is typical in routine clinical practice.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 11, 2025
First Posted
June 22, 2025
Study Start
August 15, 2024
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
June 22, 2025
Record last verified: 2025-06